n Cardiovascular Journal of South Africa - LDL cholesterol goals rapidly achieved at various starting doses of Pfizer's atorvastatin : drug trends in cardiology

Abstract

Extracted from text ... 190 Drug Trends LDL cholesterol goals rapidly achieved at various starting doses of Pfizer's atorvastatin This study provides new information on the benefits of customising treatment based on the patient's cardiovascular risk. Patients with high cholesterol can rapidly achieve target goals for LDL (low-density lipoprotein), or 'bad' cholesterol when given starting doses of 10 mg to 80 mg of the cholesterol- lowering medicine Lipitor(r) (atorvastatin calcium), according to findings from a clinical trial presented recently at the European Atherosclerosis Society (EAS).1 In the ATGOAL (Atorvastatin Goal Achievement Across Risk Levels) study, 86% of patients taking starting doses of Lipitor ..